PARSABIV Trademark

Trademark Overview

On Wednesday, February 4, 2015, a trademark application was filed for PARSABIV with the United States Patent and Trademark Office. The USPTO has given the PARSABIV trademark a serial number of 86523783. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, July 25, 2024. This trademark is owned by Amgen Inc.. The PARSABIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders
parsabiv

General Information

Serial Number86523783
Word MarkPARSABIV
Filing DateWednesday, February 4, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, July 25, 2024
Registration Number5428730
Registration DateTuesday, March 20, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 13, 2015
Primary Code005
First Use Anywhere DateWednesday, January 3, 2018
First Use In Commerce DateWednesday, January 3, 2018

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Saturday, February 7, 2015NEW APPLICATION ENTERED
Wednesday, December 9, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 13, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 11, 2015ASSIGNED TO EXAMINER
Tuesday, May 12, 2015NON-FINAL ACTION WRITTEN
Tuesday, May 12, 2015NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 5, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 5, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 7, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 9, 2017SOU EXTENSION 2 GRANTED
Tuesday, December 29, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 29, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 9, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, August 9, 2016SOU EXTENSION 1 FILED
Tuesday, August 9, 2016SOU EXTENSION 1 GRANTED
Thursday, August 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 9, 2017SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2017SOU EXTENSION 2 FILED
Tuesday, February 13, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 17, 2017SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2017SOU EXTENSION 3 FILED
Thursday, August 17, 2017SOU EXTENSION 3 GRANTED
Saturday, August 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 23, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, January 23, 2018USE AMENDMENT FILED
Monday, February 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 12, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 14, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 20, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 10, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, July 25, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 25, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 25, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 25, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

parsabiv pharmaceutical disorders treatment used preparations renal kidney parathyroid glandular hormone